Predictive Value of the Transtheoretical Model to Smoking Cessation in Hospitalized Patients with Cardiovascular Disease
Overview
Affiliations
Background: Several authors have questioned the transtheoretical model. Determining the predictive value of each cognitive-behavioural element within this model could explain the multiple successes reported in smoking cessation programmes. The purpose of this study was to predict point-prevalent smoking abstinence at 2 and 6 months, using the constructs of the transtheoretical model, when applied to a pooled sample of individuals who were hospitalized for a cardiovascular event.
Design: The study follows a predictive correlation design.
Methods: Recently hospitalized patients (n=168) with cardiovascular disease were pooled from a randomized, controlled trial. Independent variables of the predictive transtheoretical model comprise stages and processes of change, pros and cons to quit smoking (decisional balance), self-efficacy, and social support. These were evaluated at baseline, 2 and 6 months.
Results: Compared to smokers, individuals who abstained from smoking at 2 and 6 months were more confident at baseline to remain non-smokers, perceived less pros and cons to continue smoking, utilized less consciousness raising and self-re-evaluation experiential processes of change, and received more positive reinforcement from their social network with regard to their smoke-free behaviour. Self-efficacy and stages of change at baseline were predictive of smoking abstinence after 6 months. Other variables found to be predictive of smoking abstinence at 6 months were an increase in self-efficacy; an increase in positive social support behaviour and a decrease of the pros within the decisional balance.
Conclusions: The results partially support the predictive value of the transtheoretical model constructs in smoking cessation for cardiovascular disease patients.
Interventions for smoking cessation in hospitalised patients.
Streck J, Rigotti N, Livingstone-Banks J, Tindle H, Clair C, Munafo M Cochrane Database Syst Rev. 2024; 5:CD001837.
PMID: 38770804 PMC: 11106804. DOI: 10.1002/14651858.CD001837.pub4.
Smoking cessation after myocardial infarction: Findings from a cross-sectional survey in Armenia.
Hayrumyan V, Harutyunyan A, Harutyunyan T Tob Prev Cessat. 2023; 9:36.
PMID: 38090104 PMC: 10711685. DOI: 10.18332/tpc/174359.
Moqaddas A, Reisi M, Mahmoodi M, Javadzade H Addict Health. 2023; 15(2):77-86.
PMID: 37560398 PMC: 10408760. DOI: 10.34172/ahj.2023.1347.
Huo X, Li X, Gu M, Qin T, Qiao K, Bai X Tob Induc Dis. 2023; 21:70.
PMID: 37252032 PMC: 10210092. DOI: 10.18332/tid/162000.
Gaur T, Rao D, Jadhav A, Dagur L, Dhaka H, Pathak P J Family Med Prim Care. 2022; 10(11):4124-4130.
PMID: 35136777 PMC: 8797112. DOI: 10.4103/jfmpc.jfmpc_629_21.